While a relatively small sum of revenue it does bode well for the company. It's not often you find a biotech with a decent opportunity for a revenue stream to supplement the big potential payoff.
Curious as to wiser heads' views on the revenue potential for PIQ's analytical services business?
While a relatively small sum of revenue it does bode well for...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
90.5¢ |
Change
0.025(2.84%) |
Mkt cap ! $118.5M | |||
| Open | High | Low | Value | Volume |
| 88.0¢ | 93.0¢ | 87.5¢ | $277.9K | 310.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 13358 | 88.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 90.5¢ | 5241 | 1 |
View Market Depth
| Last trade - 15.58pm 06/09/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |